Coronavirus envelope protein activates TMED10-mediated unconventional secretion of inflammatory factors
- Nat Commun. 2024 Oct 8;15(1):8708. doi: 10.1038/s41467-024-52818-0.
- 1. State Key Laboratory of Membrane Biology, Tsinghua University, Beijing, 100084, China.
- 2. School of Pharmaceutical Sciences, Tsinghua University, Beijing, 100084, China.
- 3. Tsinghua University-Peking University Joint Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, 100084, China.
- 4. Key Laboratory for Experimental Teratology of Ministry of Education and Advanced Medical Research Institute, Meili Lake Translational Research Park, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
- 5. State Key Laboratory of Membrane Biology, Tsinghua University, Beijing, 100084, China. [email protected].
- 6. School of Pharmaceutical Sciences, Tsinghua University, Beijing, 100084, China. [email protected].
- # Contributed equally.
The precise cellular mechanisms underlying heightened proinflammatory cytokine production during coronavirus Infection remain incompletely understood. Here we identify the envelope (E) protein in severe coronaviruses (SARS-CoV-2, SARS, or MERS) as a potent inducer of interleukin-1 release, intensifying lung inflammation through the activation of TMED10-mediated unconventional protein secretion (UcPS). In contrast, the E protein of mild coronaviruses (229E, HKU1, or OC43) demonstrates a less pronounced effect. The E protein of severe coronaviruses contains an SS/DS motif, which is not present in milder strains and facilitates interaction with TMED10. This interaction enhances TMED10-oligomerization, facilitating UcPS cargo translocation into the ER-Golgi intermediate compartment (ERGIC)-a pivotal step in interleukin-1 UcPS. Progesterone analogues were identified as compounds inhibiting E-enhanced release of proinflammatory factors and lung inflammation in a Mouse Hepatitis Virus (MHV) Infection model. These findings elucidate a molecular mechanism driving coronavirus-induced hyperinflammation, proposing the E-TMED10 interaction as a potential therapeutic target to counteract the adverse effects of coronavirus-induced inflammation.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
-
-
-
-
Research Areas: Neurological Disease; Metabolic Disease; Inflammation/Immunology; Infection; Cardiovascular Disease
-
-
Research Areas: Cardiovascular Disease
-
Research Areas: Metabolic Disease
-
-
-
target: Androgen ReceptorResearch Areas: Endocrinology
-
-
target: 11β-HSDResearch Areas: Cardiovascular Disease
-
target: Progesterone ReceptorResearch Areas: Endocrinology
-
target: Mineralocorticoid Receptor
-
Research Areas: Neurological Disease
-
-
-
target: Progesterone ReceptorResearch Areas: Endocrinology
-
target: Adrenergic Receptor
-
target: Glucocorticoid ReceptorResearch Areas: Inflammation/Immunology
-
target: Glucocorticoid ReceptorResearch Areas: Inflammation/Immunology
-
target: Glucocorticoid Receptor